Gilead Sciences (gild) Stock Research
Last Updated by Anonymous | Update This Page Now
Company Description: Gilead Sciences, Inc. develops and markets therapeutic medicines and processes for the treatment of life-threatening infectious diseases across the world, including biopharmaceuticals for the treatment of human immunodeficiency virus infection in adults; the treatment of chronic hepatitis B; the treatment of serious invasive fungal infections; the treatment of primary pulmonary hypertension and pulmonary hypertension; the treatment and prevention of influenza A and B; and the treatment of AIDS-related Kaposis sarcoma. Update
Health Care Industry Research & Analysis: The health care industry depends on the care of health-related services by professionals for the benefit of patients. Medical device markers, insurance companies, pharmaceutical drug developers and government institutions are major participants in the treatment of sick, injured and disabled patients. Health Care Trading Strategy: Health Care stocks tend to be less sensitive to economic changes. Look for undervalued health care investments at any point in the business cycle when stock prices are low. However, biotech, employment staffing and insurance companies may all decrease during recessions for different reasons. Government intervention is another important factor in health care investments, since government spending in health care is a very large portion of overall health care spending. When governments change spending plans, different sub-sectors in the industry are significantly affected. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued.
Industry Sub Sector: .
Market Challenges: Opportunities: Solutions:
Gilead Sciences's business strategy is to keep things simple. Clearly-defined strategies lower business risks by staying within their areas of expertise. Gilead Sciences's strategy is to accomplish clear, attainable, and challenging goals. This focus increases company value and long-term investor returns.
Strategy: Gilead Sciences's strategy focus on winning more market share of price-sensitive customers by having the lowest priced products and services. (read more). Competitive Advantages:
Gilead Sciences has consistent operating results. This lowers the risk that Gilead Sciences will suddenly have difficulty and it increases investor confidence in the value they place on each share.
Current Revenue Sources: Future Revenue Sources: